Wednesday, August 31, 2016

BRIEF-AstraZeneca announces results from SYMBICORT study

* SYMBICORT demonstrated comparable risk of serious

asthma-related events and lower risk of asthma exacerbations

compared to Budesonide alone

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)